ストックスクリーナーアプリを入手
16.34
0.35%
0.0647
Dbv Technologies Adr (DBVT) 最新ニュース
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN) and Oncolytics Biotech (ONCY) - The Globe and Mail
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference - markets.businessinsider.com
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 - The Manila Times
Peanut patch helps allergic kids with asthma and eczema in trial - Stock Titan
DBV Technologies to Present New Positive Data from VITESSE - GlobeNewswire
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - markets.businessinsider.com
European ADRs Slip As Nokia And Sequans Lead Declines - Finimize
DBV Technologies Announces the Results of its 2026 Combined General Meeting - markets.businessinsider.com
symbol__ Stock Quote Price and Forecast - CNN
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy - The Manila Times
DBV Technologies Announces First Participant Screened in - GlobeNewswire
Peanut-allergic babies enter THRIVE study for skin patch therapy - Stock Titan
European ADRs Tick Higher In US Trading - Finimize
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and TG Therapeutics (TGTX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB) - The Globe and Mail
Combined General Meeting of June 3, 2026 - Moomoo
European ADRs Rose Monday, With Biotech Names Leading Moves - Finimize
MPM BioImpact reports 8.8% stake in DBV Technologies (DBVT) - Stock Titan
Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Immunic (IMUX) and Protara Therapeutics (TARA) - The Globe and Mail
Adage insiders report 22,272,884 shares in DBV Technologies (NASDAQ: DBVT) - Stock Titan
Artisan Partners (DBVT) discloses 2,219,386 ADS; 3.7% stake reported - Stock Titan
Vivo Opportunity (DBVT) holds 2.36M ADSs — 4.0% ownership disclosed - Stock Titan
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq - markets.businessinsider.com
DBV Technologies (NASDAQ: DBVT) lines up 40 proposals for 2026 shareholder meeting - Stock Titan
DBV Technologies (DBVT) grants 1.74M performance share units to CEO - Stock Titan
Invus affiliates disclose 17.998M DBV ordinary shares (DBVT) — 6.1% reported - Stock Titan
DBVT Stock Price, Quote & Chart | DBV TECHNOLOGIES SA-SPON ADR (NASDAQ:DBVT) - ChartMill
DBV Technologies (DBVT) ramps Q1 2026 spending but extends cash runway - Stock Titan
DBV Technologies Reports First Quarter 2026 Financial Results - The Manila Times
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance
DBV Technologies (NASDAQ: DBVT) director Philina Lee files initial Form 3 ownership - Stock Titan
Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should Know - Zacks Investment Research
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight - GlobeNewswire Inc.
Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA – American (DBVT) - The Globe and Mail
Combined General Meeting of June 11, 2025 - NTB Kommunikasjon
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
DBV technologies S.A. (ADR) (DBV1.SG) Stock Forum & Discussion - Yahoo! Finance Canada
DBV technologies S.A. (ADR) (DBV1.SG) Stock Major Holders - Yahoo! Finance Canada
DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Friday - Defense World
DBV technologies S.A. (ADR) (DBV1.SG) company profile and facts - Yahoo Finance UK
Cantor Fitzgerald reiterates DBV Technologies stock rating on patch potential - Investing.com
Guggenheim Reiterates “Buy” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World
Alphabet To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Citizens raises DBV Technologies stock price target on allergy drug outlook - Investing.com
DBV Technologies Reports Full Year 2025 Financial Results and Business Update - markets.businessinsider.com
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - The Manila Times
4.93%
0.20%
大文字化:
|
ボリューム (24 時間):